[Pubmed] Commentary: Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia g
Posté : 03 juin 2024 12:00
Front Immunol. 2024 May 17;15:1403802. doi: 10.3389/fimmu.2024.1403802. eCollection 2024.
NO ABSTRACT
PMID:38827748 | PMC:PMC11141541 | DOI:10.3389/fimmu.2024.1403802
Source: https://pubmed.ncbi.nlm.nih.gov/3882774 ... t9+e462414